Skip to main content
Fig. 2 | Journal of Nanobiotechnology

Fig. 2

From: Rhamnolipid-coated W/O/W double emulsion nanoparticles for efficient delivery of doxorubicin/erlotinib and combination chemotherapy

Fig. 2

Synergetic effect between two drugs and the in vitro tumor cell-killing effect of RL-NP-DOX-ERL. a Cell viability after treatment with varying ratios of DOX and ERL (n = 6). b Combinational index (CI) values calculated based on data in a. c Cell viability after treatment with bare RL-NP, RL-NP-DOX, RL-NP-ERL, and RL-NP-DOX-ERL (n = 6)

Back to article page

Journal of Nanobiotechnology

ISSN: 1477-3155

Contact us